Clinical Trials Logo
  1. Home
  2. HbA1C
  3. NCT04965051

Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T1DM

HbA1c Clinical Trial

Official title:
A Prospective, Randomized, Open-label, Parallel Group Study to Evaluate Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With Type 1 Diabetes Mellitus

Clinical Trial Summary

In this prospective, randomized, open-label, parallel group trial, the safety and efficacy of insulin degludec/insulin aspart (IDegAsp) twice daily will be compared with basal insulin once or twice daily plus pre-prandial insulin after 16 weeks of treatment in patients with type 1 diabetes. This trial will enable assessment of the clinically relevant endpoint of a change in HbA1c and Time in Range (TIR).

Clinical Trial Description

The objective of the current study is to investigate the efficacy and safety of IDegAsp twice daily compared to basal insulin once or twice daily plus pre-prandial insulin for 16 weeks in patients with type 1 diabetes mellitus. The primary endpoint in this study is the change from baseline in HbA1c. Patients with type 1 diabetes who meet the entry criteria are planned for inclusion in this trial. Approximately 40 patients will be enrolled in the study. Patients who qualify will be randomized to IDegAsp group or basal plus pre-prandial insulin group. Duration of treatment includes 2-week screening period, 16-week treatment observation period and 1-week follow-up. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04965051
Study type Interventional
Source Second Affiliated Hospital, School of Medicine, Zhejiang University
Contact Yuezhong Ren, MD
Phone +86 0571 87783516
Email renyuez@zju.edu.cn
Status Recruiting
Phase N/A
Start date August 2021
Completion date December 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT05394532 - Steno Diabetes Dialogue Cards Teaching on Group Education on Blood Sugar Control in Adolescents With Type 1 Diabetes N/A
Recruiting NCT05584085 - ACT-DE for Diabetes Distress and HbA1c in Adults With Type 2 Diabetes N/A
Completed NCT04132128 - SUCCEED - Soroka Utility for Counting Carbs Easily and Effectively for Diabetes N/A
Completed NCT04125160 - Glycaemic Markers in Persons With Type 2 Diabetes on Peritoneal Dialysis
Completed NCT03957603 - Medical Nutrition Therapy Combined With TPF-DM in Pregnant Women With Gestational Diabetes Mellitus N/A
Completed NCT05030844 - The Effect of IMB Model-Based Diabetes Education and Motivational Interviewing on Care Outcomes in Adults With T2DM N/A
Active, not recruiting NCT03333044 - Diabetes Management Intervention For South Asians N/A
Completed NCT04020445 - Simplification of Complex Insulin Regimens With Preserving Good Glycemic Control in Type 2 Diabetes
Not yet recruiting NCT04131608 - Effect of Iron Deficiency Anemia on HBA1C in Patients With Diabetic Foot Ulcer Grade (1and2)
Completed NCT06140108 - Empagliflozin vs Metformin on Metabolic Dysfunction in Polycystic Ovary Syndrome With or Without Comorbidity or Multimorbidity Phase 2/Phase 3
Recruiting NCT04736277 - HbA1c and Neurocognitive Disorders
Active, not recruiting NCT05355090 - Daily Protein Pacing Effects on HbA1c in Type 2 Diabetics N/A
Completed NCT04694326 - The Incidence of Diabetes Unawareness in Patients Hospitalized Outside Internal Medicine Services and Related Factors